Fundz

Colossal Biosciences raised more than $225 million in funding to pursue de-extinction of prehistoric creatures and conservation efforts.

PRIVATEApr 12, 2024

Amount Raised

$225 Million

Round Type

Funding Round

AustinBiotechnology

Investors

At One VenturesBob NelsenBreyer CapitalBold Capital PartnersUsit

Description

Colossal Biosciences has raised more than $225 million to date, with backers including USIT, Bold Capital Partners, Breyer Capital, Bob Nelsen, At One Ventures, and more. The company continues to pursue the de-extinction of the woolly mammoth, the Tasmanian tiger, and the dodo, alongside extensive conservation efforts.

Quick answer

Colossal Biosciences raised $225 Million in a Funding Round round, dated April 12, 2024. Investors: At One Ventures, Bob Nelsen, Breyer Capital, Bold Capital Partners and Usit. Colossal Biosciences is based in Austin, Texas, United States.

How much did Colossal Biosciences raise?
Colossal Biosciences raised $225 Million in a Funding Round round on April 12, 2024.
Who invested in Colossal Biosciences?
At One Ventures, Bob Nelsen, Breyer Capital, Bold Capital Partners and Usit are named as investors in this round.
What does Colossal Biosciences do?
Colossal was founded by emerging technology and software entrepreneur Ben Lamm and world-renowned geneticist and serial biotech entrepreneur George Church, Ph.D., and is the first to apply CRISPR technology for the..
Where is Colossal Biosciences based and how big is it?
Colossal Biosciences is based in Austin, Texas, United States. Fundz records about 174 employees.
Who are the decision-makers at Colossal Biosciences?
Fundz holds 1 contact at Colossal Biosciences. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Colossal Biosciences that raised within 45 days of this round, from Fundz verified event records.

  • MyndTec raised $100K (Pre-Seed) on May 27, 2024.
  • Bionano Genomics raised $20M on May 24, 2024.
  • Bicycle Therapeutics raised $555M (Post-IPO Equity) on May 23, 2024.
  • Radar Therapeutics raised $13M (Seed) on May 23, 2024.
  • Turn Therapeutics Inc. raised an undisclosed amount on May 23, 2024.
  • Grey Wolf Therapeutics raised $50M (Series B) on May 23, 2024.

Who to call at Colossal Biosciences, and when

A new round usually means Colossal Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Colossal Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Colossal Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Colossal Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Colossal Biosciences

Location

Austin, Texas, United States

About

Colossal was founded by emerging technology and software entrepreneur Ben Lamm and world-renowned geneticist and serial biotech entrepreneur George Church, Ph.D., and is the first to apply CRISPR technology for the purposes of species de-extinction. Colossal creates innovative technologies for species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. Colossal is accepting humanity's duty to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition through cutting-edge science and technologies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Colossal Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Colossal Biosciences's next move

See what Strategic adds

Colossal Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.